Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Low-dose aspirin use and endometrial cancer mortality-a Danish nationwide cohort study

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Cohort Profile: The Copenhagen Child Cohort Study (CCC2000)

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Data Resource Profile: Committee of Nordic Assisted Reproductive Technology and Safety (CoNARTaS) cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Endometrial cancer risk after fertility treatment: a population-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. HPV types, cervical high-grade lesions and risk factors for oncogenic human papillomavirus infection among 3416 Tanzanian women

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Gynaecological cancer leads to long-term sick leave and permanently reduced working ability years after diagnosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Cecilie D Sperling
  • Freija Verdoodt
  • Gitte L Aalborg
  • Christian Dehlendorff
  • Søren Friis
  • Susanne K Kjaer
View graph of relations

BACKGROUND: Accumulating evidence suggests that aspirin use may improve survival in cancer patients, however, for endometrial cancer, epidemiological evidence is limited and results are equivocal. In a nationwide cohort study, we examined the association between post-diagnostic low-dose aspirin use and endometrial cancer mortality.

METHODS: From the Danish Cancer Registry, we identified all women with a primary diagnosis of endometrial cancer. Women diagnosed between 2000 and 2012, aged 30-84 years, who had no history of cancer (except non-melanoma skin cancer) and were alive 1 year after the cancer diagnosis were eligible. We obtained information on pre- and post-diagnostic use (≥1 prescription) of low-dose aspirin, mortality and potential confounding factors from nationwide registries. Using Cox regression models, we estimated adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between post-diagnostic low-dose aspirin use and endometrial cancer mortality. The exposure was modelled as both time-varying as well as time-fixed within exposure windows of 1 and 5 years.

RESULTS: We identified 6694 endometrial cancer patients with a maximum follow-up of 13 years. In the time-varying analysis, post-diagnostic low-dose aspirin use was associated with a HR of 1.10 (95% CI 0.90-1.33) for endometrial cancer mortality. We found no indication of a dose-response association according to increasing tablet strength, cumulative amount or duration of use, and the HRs were similar for pre-diagnostic and post-diagnostic low-dose aspirin use compared with non-use.

CONCLUSIONS: We found no indication that post-diagnostic low-dose aspirin use was associated with reduced mortality for endometrial cancer; rather our findings suggested a concern for increased mortality.

Original languageEnglish
JournalInternational Journal of Epidemiology
Volume49
Issue number1
Pages (from-to)330-337
Number of pages8
ISSN0300-5771
DOIs
Publication statusPublished - 1 Feb 2020

    Research areas

  • Adult, Aged, Aged, 80 and over, Anti-Inflammatory Agents, Non-Steroidal/administration & dosage, Aspirin/administration & dosage, Cause of Death, Cohort Studies, Denmark/epidemiology, Endometrial Neoplasms/mortality, Female, Humans, Middle Aged, Proportional Hazards Models, Registries, Risk Factors, Survival Analysis

ID: 61593974